Search results
Why everyone is not convinced about Dr Reddy’s latest acquisition
CNBC Awaaz· 3 days agoDr Reddy’s will have to invest significantly to improve growth rates of the acquired brands in...
Emcure Pharma IPO: GMP surges on last day; issue subscribed 24 times so far - CNBC TV18
CNBC TV18· 3 hours agoThe initial share sale of Emcure Pharmaceuticals was off to a strong start on the last day of the...
Buy Dr. Reddy's Laboratories, target price Rs 6500: Prabhudas Lilladher
The Economic Times· 4 days agoDr. Reddy's Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 106802.89 Crore) operating in Pharmaceuticals sector.
Pharma shares shine; Dr Reddy's, FDC, Glenmark, Suven trade at record highs
Business Standard India· 2 days agoShares of pharmaceutical companies were in focus, and rallied up to 12 per cent on the BSE in...
Zydus, Dr Reddy's to co-market breast cancer treatment in India
CNBC Awaaz· 7 days agoPertuzumab is a critical treatment for HER2 positive breast cancer patients and the biosimilar has...
Dr. Reddy's Laboratories Limited
CNBC Awaaz· 5 days agoDr. Reddy's Laboratories Limited
Zydus Life shares gain on licensing agreement with Dr Reddy’s to market Pertuzumab Biosimilar
CNBC Awaaz· 4 days agoZydus Lifesciences share price was up marginally percent in the opening trade on July 1 after the...
Stocks to watch: Zydus Lifesciences, Dr Reddy's, Cochin Shipyard, and PTC Industries shares in focus
Firstpost· 4 days agoThe Indian stock market is likely to start the day on a flat note. Asian stocks have given mixed...
Dr. Sivaramakrishnan S - What Are The Common Scalp Conditions?
Outlook India· 5 hours agoDiscover common scalp conditions like dandruff, head lice, and ringworm. Learn how proper hair washing techniques and good hygiene practices can help manage and prevent these issues, keeping ...
Adani Enterprises, ICICI Bank, Dr Reddy's: Trading strategies for these buzzing largecap stocks
Business Today· 4 days agoAn analyst from Arihant Capital observes Adani Enterprises testing the 200-days SMA (Rs 2,833) by...